Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
12-month diagnosed prevalent cases of severe asthma across 8MM to reach 1.89 million in 2033,…
GlobalData predicts a steady rise in severe asthma cases across 8MM, driven by population growth and evolving risk factors
B&R drives adaptive manufacturing solutions in pharma production
B&R is collaborating with OEMs, machine manufacturers, and end-users in the pharmaceutical sector to implement adaptive…
SPARC partners with UCSF and Tiller Therapeutics to license oncology asset
Agreement grants SPARC equity in Tiller for development and commercialisation of joint oncology intellectual property
Yugal Sikri outlines 3 key trends defining India’s pharma growth in 2025
Market consolidation, AI-driven innovation, and supportive government policies are set to propel India's pharma industry toward…
Granules Pharmaceuticals gains U.S. FDA approval for Lisdexamfetamine Dimesylate chewable tablets
New approval supports treatment for ADHD and binge eating disorder while addressing critical drug shortages
Schizophrenia market to reach $17 billion in 7MM by 2031, forecasts GlobalData
Pipeline innovations set to drive schizophrenia market growth despite generic competition
Unmet needs in chronic hand eczema present clear demand for new treatments: GlobalData
Innovative therapies targeting inflammation offer hope for improved chronic hand eczema care
Gerresheimer: FDA grants tentative approval of SQ innovation’s Lasix ONYU
Patented device technology for precise administration
Biocon Biologics’ Ustekinumab Biosimilar receives positive CHMP opinion
YESINTEK recommended for approval to treat psoriasis, psoriatic arthritis, and Crohn’s disease in adults and children
Anil Matai reflects on 2024 as a pivotal year for India’s pharma sector
OPPI DG highlights government initiatives and industry efforts shaping a patient-centric, innovation-driven future